Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative piperacillin/tazobactam strategy after pancreaticoduodenectomy in patients with preoperative biliary stent
2021-006991-18Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Jan 2023
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of piperacillin + tazobactam in surgical site infection (SSI) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Presence of organ/space surgical site infection. Started Jan 2023; status: active.
02
Drugs
piperacillin + tazobactam
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2021-006991-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006991-18.